Worth Venture Partners »

Applied Therapeutics shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 413k 3.35
2023-09-30 $483k 194k 2.49

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Applied Therapeutics

Alyeska Investment Group
Franklin Resources
VR Adviser
Knoll Capital Management
Propel Bio Management
Perceptive Advisors
Vanguard Group
Simplify Asset Management
Henderson Group
Logos Global Management
AIGH Capital Management
Opaleye Management
Millennium Management
Schonfeld Strategic Advisors
Point72 Asset Management

View all funds holding Applied Therapeutics